Johnson & Johnson acquires Momenta Pharmaceuticals for $6.5b | EKF Diagnostics Holdings plc (EKF.L): Strategic Investment
20 Aug 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
EKF Diagnostics Holdings plc (EKF:LON) | 27.8 0.3 4.5% | Mkt Cap: 126.1m
- Published:
20 Aug 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Johnson & Johnson acquires Momenta Pharmaceuticals for $6.5b | EKF Diagnostics Holdings plc (EKF.L): Strategic Investment